Bacterial Cytotoxins IgM

Optimal result: 0 – 2.3 ELISA Index

Bacteria such as E. coli, Salmonella, Shigella and C. jejuni, are members of the bacteria that participate in diseases that involve the disruption of a mucosal or epithelial layer.

By producing cytotoxins, these bacteria affect the delicate environment of the small intestine, and then gain entry into the cell, where by binding to the cellular DNA, they induce apoptosis. They find their way to the submucosa, regional lymph nodes, and into circulation where the immune system responds by producing antibodies against them. Indeed, in vitro studies have shown that human epithelial cells are native targets of the CdtB expressed by these bacteria.

Cell infiltration by CdtB induces DNA damage which signals growth arrest at the G2/M (state of cell growth and division) interphase of the cell cycle.

The epithelium is an early line of defense in the oral cavity and the gastrointestinal system against microbial assault.

When damaged, bacteria collectively gain entry into the underlying connective tissue where microbial products can affect processes and pathways culminating in the destruction of the epithelial barrier and the underlying tissue. Antibodies against Bacterial Cytotoxins indicate gut dysbiosis with the potential for causing intestinal barrier damage.

Bacterial Cytotoxins refer to the cytolethal distending toxin, subunit B (CdtB) that is released by Escherichia coli, Salmonella, Shigella and Campylobacter jejuni. Utilizing subunits A and C, gram-negative bacteria can bind to human cells, allowing CdtB to infiltrate the cell. Inside the cell, CdtB contributes to cytoskeletal damage, which may induce apoptosis (cell death). CdtB is the first bacterial toxin known to act in the nucleus of a target cell.

Associated With:

- Irritable bowels

- SIBO

- Gut dysbiosis

- Chronic functional bowel changes

- Localized aggressive periodontitis

Bacterial Cytotoxins refer to the cytolethal distending toxin, subunit B (CdtB) that is released by Escherichia coli, Salmonella, Shigella and Campylobacter jejuni. Utilizing subunits A and C, gram-negative bacteria can bind to human cells, allowing CdtB to infiltrate the cell. Inside the cell, CdtB contributes to cytoskeletal damage, which may induce apoptosis (cell death). CdtB is the first bacterial toxin known to act in the nucleus of a target cell.

Associated With:

- Irritable bowels

- SIBO

- Gut dysbiosis

- Chronic functional bowel changes

- Localized aggressive periodontitis

--------------------

Cyrex Array 22 measures IgA, IgG and IgM antibodies against bacterial cytotoxins and cytoskeletal proteins in human blood. This is based on the scientific fact that bacteria from the colon move up to the upper gut, and their concentrations become elevated. By producing cytotoxins, these bacteria affect the delicate environment of the small intestine, and then gain entry into the cell, where, by binding to the cellular DNA, they induce apoptosis (cell death). They then find their way to the submucosa, regional lymph nodes, and into the circulation. Immune response against the bacterial cytotoxins may result in the production of IgA, IgM and IgG antibodies against them.

Due to the antigenic similarity between E. coli, Salmonella, Shigella toxins, Campylobacter jejuni and human cytoskeletal proteins such as vinculin and talin, these antibodies cross-react with the cytoskeletal proteins, causing depolymerization of and release of these proteins from the epithelial cells, with subsequent antibody production against the cytoskeletal proteins vinculin, talin, and actinin. These IgA, IgM and IgG antibodies against bacterial cytotoxins and cytoskeletal proteins are detected in the blood with high accuracy and reproducibility. Thus, bacterial over-growth can be an instigator of extra-intestinal autoimmunity (autoimmune reactivity outside of the gastrointestinal tract).

Cytotoxins are lethal xenobiotics released by commensal coliform bacteria. Bacterial cytotoxins can destroy epithelial cells of the intestinal barrier. Therefore, Cyrex also assesses antibodies to cytoskeletal proteins. Once this epithelial cell damage occurs, bacterial cytotoxins can freely enter circulation. Like systemic lipopolysaccharides, when bacterial cytotoxins enter the blood stream, they produce chronic inflammation and can permeate the blood brain barrier. 

Bacterial Cytotoxins IgM
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Bacterial Cytotoxins IgM — 10,000+ markers explained
One Bacterial Cytotoxins IgM result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro